Faintuch joel (97 resultados)

Hardcover. Condición: Wie neu. 2. Auflage. New book, remains sealed in plastic. Language - English. Ships from Berlin.

Condición: Used. 282.

Condición: Used. 282.

Condición: Used. 282.

Condición: New.

Condición: New. pp. 312 2013th edition NO-PA16APR2015-KAP.

Condición: New. In English.

Condición: New. In English.

Condición: Wie Neu. Zustandsbeschreibung: leichte Lagerspuren/minor shelfwear. Edited by Joel Faintuch & Salomao Faintuch. Major surgical societies have been publishing perioperative recommendations for over half a century, based on committees conducting reviews of the literature. Surgical books fundamentally target the intraoperative period when anesthesia is going on. Fatalities are often embedded in a larger context of systemic failures, in which initial problems are sidestepped or mishandled till they become overwhelming and irreversible. There must be a guiding principle and a truly integrated approach for each condition and treatment, of course based on the strongest available evidence. This book provides the reader standardized instructions and recommendations on the management of all high-risk surgical candidates in different specialties and contexts, encompassing a continuum of care, and not just in selected phases or groups. XVI,765 Seiten mit 70 Farb- und 22 s/w-Abb., gebunden (Springer 2024). Statt EUR 213,99. Gewicht: 1426 g - Gebunden/Gebundene Ausgabe.…

hardcover. Condición: Very Good.

Condición: New. pp. 1009 2nd Edition NO-PA16APR2015-KAP.

Hardcover. Condición: Brand New. 1st edition. 608 pages. 10.00x7.00x1.50 inches. In Stock.

Taschenbuch. Condición: Neu. Disabling Obesity | From Determinants to Health Care Models | Paolo Capodaglio (u. a.) | Taschenbuch | viii | Englisch | 2015 | Springer | EAN 9783642426506 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Condición: New.

Taschenbuch. Condición: Neu. Obesity and Diabetes | Scientific Advances and Best Practice | Joel Faintuch (u. a.) | Taschenbuch | xv | Englisch | 2021 | Springer | EAN 9783030533724 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Condición: New. pp. 1009.

Condición: New. In English.

Condición: As New. Unread book in perfect condition.

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Obesity is currently regarded as one of the major health challenges of the developed world. Excess body weight is an important risk factor for morbidity and mortality from cardiovascular diseases, diabetes, cancer, musculoskeletal disorders and even psychiatric problems and is estimated to cause nearly 3 million deaths per year worldwide. Obesity is not necessarily associated with comorbidities: there are indeed metabolically healthy obese individuals. Thus, we need to consider individuals presenting simple with obesity separately from those at risk of developing or who have already developed complex clinical states potentially leading to disability. Comorbidities can tip the balance of independence in patients who already have functional limitations mainly due to the excess of mass itself or who develop conditions such as diabetes, cardiovascular conditions, non-alcoholic fatty liver disease, where an abnormal metabolism of adipose tissue prevails. Morbid obesity with comorbidities leading to disability represents a real social and economic burden for National Health Systems worldwide. The presence of multiple and associated comorbidities often represents an obstacle to being admitted to hospitals for the treatment of metabolic diseases. On the other hand, clinical units with optimal standards for the treatment of pathological conditions in normal-weight patients are often structurally and technologically inadequate for the care of patients with extreme obesity. The aim of this book is to focus on the pathophysiological and rehabilitative aspects of disabling obesity, highlighting multidisciplinary rehabilitation interventions as key to counteracting the disabling aspects of complicated obesity. …

Paperback. Condición: Brand New. reprint edition. 304 pages. 9.25x6.10x0.71 inches. In Stock.

Taschenbuch. Condición: Neu. Recent Strategies in High Risk Surgery | Joel Faintuch (u. a.) | Taschenbuch | xvi | Englisch | 2025 | Springer | EAN 9783031562723 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Condición: New. pp. 314.

Condición: New. In English.

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New. 1st ed. 2022 edition NO-PA16APR2015-KAP.

Condición: New.

Condición: New. In English.

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Now in its second edition, this comprehensive handbook provides a state-of-the-art overview of recent advances in drug and non-drug therapies for obesity and diabetes. It also addresses major comorbidities, covering topics such as, cardiovascular diseases, renal and neuropsychiatric disorders, appetite control and micro RNAs. Special attention is also devoted to pediatric care, including the latest recommendations for therapy and prevention. Obesity and type 2 diabetes are among the top global health-care budget concerns worldwide and impact professional practice at all levels: in hospitals, clinics and physicians' offices alike. They prominently feature in headlines, and virtually no family, community or country is exempt from their protean, deleterious consequences. Furthermore, given the multiple intersections in their pathways, they often go hand in hand.The good news is that scientific advances in all fields, including genomics, metabolomics, lipidomics and microbiomics, are increasing our understanding of these two disease areas. At the same time, artificial intelligence, machine learning, mobile health and advanced implantable and external devices are rendering prevention and management more available, safe and cost-effective. In addition, bariatric and metabolic surgery has evolved from a niche specialty to an officially endorsed option for several modalities of obesity and diabetes. This book presents the latest lifestyle, pharmacological, surgical and non-surgical treatment options, including endoscopic intervention and cell therapy. Objectively reviewing natural and artificial sweeteners and critically examining issues such as public health initiatives, government mandated taxes for unhealthy foods and environmental planning, no stone is left unturned in gathering the latest practical information. As such, the book will appeal to seasoned specialists, as well as students and healthcare professionals in training.…

Condición: New. pp. 628.